rethinkTHC Search
Menu
Study breakdown

High doses of CBG impaired sustained attention in female rats but not males, despite marketing claims of cognitive enhancement

Animal StudyPreliminary evidence
The takeaway

In rats given oral CBG at doses up to 600 mg/kg, females showed attention deficits at the highest doses while males were unaffected, and females had significantly higher blood levels of CBG than males.

CBG product consumers, cannabis supplement researchers, pharmacologists studying sex differences

Attention deficits at 300-600 mg/kg in females only; females had higher plasma CBG levels

What the researchers found

CBG at 300-600 mg/kg impaired sustained attention in female rats but not males. CBG did not affect motivation or working memory in either sex. Females had significantly higher circulating CBG plasma levels than males after the same oral dose.

Why it matters

CBG is increasingly marketed as a cognitive enhancer for focus and attention. This is the first controlled study to test those claims, and it found the opposite: high-dose CBG impaired attention in females.

The numbers in context

Doses: 30-600 mg/kg oral. Attention deficits at 300-600 mg/kg in females only. No effects on motivation or working memory. Females had significantly higher plasma CBG levels than males.

How the study worked

Male and female adult Sprague Dawley rats received oral CBG (30-600 mg/kg) or vehicle before testing on rodent psychomotor vigilance (attention), progressive ratio responding (motivation), and spontaneous alternation (working memory). Blood collected 60 minutes post-administration for plasma CBG levels.

What this study cannot tell us

Animal study; rat doses may not directly translate to human doses. Acute dosing only. The attention deficit was only at very high doses.

How to read the evidence

Well-controlled animal study with multiple behavioral measures and pharmacokinetic data, but rat findings require human confirmation.

When this study was published

2026 publication

The bigger picture

The cannabis supplement market makes unsubstantiated cognitive enhancement claims. This study shows minor cannabinoids may have sex-specific effects and that higher doses do not necessarily mean better outcomes.

Questions still open

  • Why do females absorb more CBG? Would lower, human-comparable doses also affect attention? Could the sex difference be relevant to human CBG users?

Common questions

Does CBG improve focus and attention?
Despite marketing claims, this study found the opposite at high doses in female rats. No cognitive benefits were observed at any dose in either sex.
Why were females more affected?
Females had significantly higher CBG blood levels after the same dose, likely due to differences in metabolism or body composition.

Read the original research

High doses of orally administered cannabigerol produce deficits in sustained attention in female rats.

Pharmacology, biochemistry, and behavior, 260, 174154

Citation

Moore, Catherine F; Bergeria, Cecilia L; Sempio, Cristina; Klawitter, Jost; Christians, Uwe; Weerts, Elise M. (2026). High doses of orally administered cannabigerol produce deficits in sustained attention in female rats.. Pharmacology, biochemistry, and behavior, 260, 174154. https://doi.org/10.1016/j.pbb.2026.174154

Explore the wider topic